Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours
| Image |  |
|---|---|
| Description | scientific article published on 24 May 2019 |
| Author/s |
author: Kenji Tamura Shunsuke Kondo Toshio Shimizu Kan Yonemori Shigehisa Kitano Akihiko Shimomura |
| Publication date | May 24, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |